category
news
release
media
information
EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells
EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT
Announcement of Capital Reduction
EditForce completed fund raising by third-party allotment and AMED adopts our program
EditForce completed fund raising by third-party allotment
EDITFORCE AND SOLASIA ENTER INTO JOINT R&D AGREEMENT
EditForce raises 870 million JPY
archive
All
Feel free to contact us when you have any questions or concerns.
